Page 15 - Siam Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

"); document.write(" "); document.write("cX.callQueue.push(['invoke', function() { "); document.write("googletag.cmd.push(function() { googletag.display('div-gpt-ad-Mobile_TSOL_ROS_Mid_Mobile_RichMedia'); googletag.pubads().refresh([gptAdSlots[8]]);});"); document.write("}]);"); document.write(""); document.write("ipt>"); document.write(""); } else { var dcw=0; if(!window.innerWidth) //IE if(!(document.documentElement.clientWidth==0))dcw=document.documentElement.clientWidth; //strict mode else dcw=document.body.clientWidth; //quirks mode else dcw=window.innerWidth; //w3c lef...

Friday, 16 Jul 2021 09:06 AM MYT Siam Bioscience is owned by King Maha Vajiralongkorn. — Reuters pic Follow us on Instagram and subscribe to our Telegram channel for the latest updates. BANGKOK, July 16 — AstraZeneca is seeking to delay delivery of 61 million doses of its Covid-19 vaccines to Thailand by five months, a Thai official said Thursday, as the South-east Asian country weighs vaccine export curbs to shore up domestic supplies. At the centre of the drug maker’s regional supply challenge is its local production partner Siam Bioscience, which has been shrouded in a veil of se...

news AstraZeneca delays 61m doses The Bangkok Post Govt vaccine rollout dealt further blow © The Bangkok Post A health worker administers Covid-19 vaccine by AstraZeneca at the Bang Sue Grand Station in Bangkok last month. (Photo: Varuth Hirunyatheb) AstraZeneca has asked Thailand to extend the timeline for the delivery of 61 million doses of its Covid-19 vaccine until May next year, Deputy Public Health Minister Sathit Pitutecha said. The move is expected to disrupt the country’s already-slow vaccine rollout further. In an interview with the Bangkok Post, Mr Sathit said ...

At the centre of the drug maker's regional supply challenge is its local production partner Siam Bioscience, which has been shrouded in a veil of secrecy. BANGKOK: AstraZeneca is seeking to delay delivery of 61 million doses of its COVID-19 vaccines to Thailand by five months, a Thai official said Thursday, as the Southeast Asian country weighs vaccine export curbs to shore up domestic supplies. At the centre of the drug maker's regional supply challenge is its local production partner Siam Bioscience, which has been shrouded in a veil of secrecy. ROYAL OWNERSHIP Siam Bioscience is owned by K...

Thailand to limit locally-manufactured AstraZeneca vax exports ​ By IANS | ​ 3 Views   Photo taken on March 12, 2021 shows AstraZeneca/Oxford vaccines at a hospital in Caceres province in Spain. (Photo by Gustavo Valiente/Xinhua/IANS). Image Source: IANS News Bangkok, July 15 : Thailand plans to set a limit on its exports of locally-manufactured AstraZeneca Covid-19 vaccines to meet domestic demand as the country is struggling to contain a months-long resurgence, a senior official said, The Disease Control Department and the National Vaccine Institute (NVI) have agreed to impose a quot...